Skip to content

Class Action Lawsuit Filed Against C3.ai Over Alleged Misleading Statements

Investors claim C3.ai hid the truth about its growth and the impact of its CEO's health on the company's performance. A lawsuit seeks to hold the company accountable.

In this image, we can see an advertisement contains robots and some text.
In this image, we can see an advertisement contains robots and some text.

Class Action Lawsuit Filed Against C3.ai Over Alleged Misleading Statements

A class action lawsuit has been initiated against C3.ai, Inc. (NYSE: AI) on behalf of investors who bought the company's shares between February 26, 2025 and August 8, 2025. The lawsuit alleges that the company's executives made misleading statements about its growth and failed to disclose the impact of the CEO's health issues on the company's performance.

C3.ai announced disappointing financial results and reduced revenue guidance on August 8, 2025. The company attributed the poor performance to a reorganization and the health issues of its then-CEO, Stephen Ehikian, who was appointed in September 2025. Following this announcement, the price of C3.ai's stock fell by approximately 25.58% in a single day. The lawsuit, filed by Levi & Korsinsky, LLP, alleges that C3.ai's executives made false and misleading statements about the company's growth and failed to disclose the significant impact of the CEO's health on the company's ability to close deals. Investors who suffered losses during this time have until October 21, 2025 to request appointment as lead plaintiff in the lawsuit.

The lawsuit against C3.ai, Inc. is ongoing, with the law firm Levi & Korsinsky, LLP representing the plaintiffs. The outcome of the lawsuit may have significant implications for the company and its shareholders.

Read also:

Latest